88%Confidence
0Views
FDASource
2026-03-10Date
Summary
Vista Tears eye drops recalled due to lack of sterility assurance, further implicating Omni Lens's manufacturing practices. This expands the quality issue beyond diagnostic strips to lubricant drops, suggesting widespread cGMP failures at the facility.
Actionable: Evaluate the financial stability of distributors like hi-health and HUB Pharmaceuticals due to escalating recall scope.
AI Confidence: 88%
Data Points
firmWizcure Pharmaa Private Limited
classificationClass II
statusOngoing
distributionDistributed Nationwide in the USA
productVista Tears Polyethylene Glycol 400 0.4% w/v, Propylene Glycol 0.3% w/v Eye Drops, Dry Eye Relief, Lubricant Drops, Sterile 10 ml (1/3 fl. oz.), Manuf
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now